Quince Therapeutics, Inc. ($QNCX)
Filing Information
| Accession Number | 0000912282-26-000830 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 15, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
2,700
Total Value
$0.00
P&L
+inf% (+$2,513.70)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Director Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Grant/Award | 2,700 | $0.00 | $0.00 | 2,700 | Direct | โ | View Details |